While most foods act indirectly, alfalfa is one of the few that has a direct triggering mechanism. This plant, often found in “health” salads, vegetarian sandwiches, or certain dietary supplements, contains L-canavanine. This is a non-protein amino acid that is structurally similar to arginine. The body mistakenly incorporates it into its own proteins, which alters their structure. The immune system, no longer recognizing these modified proteins, mounts a massive attack against its own tissues. In a patient with lupus, consumption of alfalfa sprouts or mung bean sprouts can worsen autoantibody activity. It is essential to avoid these foods, as clinical observations have shown that they can reactivate native anti-DNA antibodies and trigger severe joint pain, even during a period of stable remission.
While alfalfa is prohibited in lupus patients because it contains L-canavanine, garlic (Allium sativum), on the other hand, should be avoided for the opposite reason: its stimulating effect on the immune system is too strong. Garlic contains sulfur compounds, including allicin and thiosulfates, which have potent immunostimulant properties. In a healthy person, these molecules strengthen natural defenses, but in a lupus patient, they worsen the imbalance of the immune system. By stimulating the activity of macrophages and T lymphocytes, garlic increases the production of autoantibodies and can turn a stable phase of the disease into an acute inflammatory flare-up.
This vigilance extends beyond fresh garlic cloves: garlic powder and garlic extracts found in prepared foods and so‑called “detox” dietary supplements are also involved.
Along the same lines as garlic, echinacea is a medicinal plant whose “natural” reputation masks a danger for patients with lupus. Often taken as herbal teas, capsules, or tinctures to prevent colds, it acts by increasing the production of pro-inflammatory cytokines (TNF-α, IFN-γ). Clinical observations have shown that echinacea can not only interfere with immunosuppressive treatments by cancelling out their effects, but also trigger a reactivation of autoimmune activity in patients who were previously stable. By driving lymphocytes to proliferate, it may disrupt the patient’s already fragile immune tolerance and push the body into a new flare.